These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patients. Kovacicová G; Spánik S; Kunová A; Trupl J; Sabo A; Koren P; Sulcová M; Mateicka F; Novotný J; Pichnová E; Jurga L; Chmelík B; Obertik T; West D; Krcéry V Scand J Infect Dis; 2001; 33(5):367-74. PubMed ID: 11440223 [TBL] [Abstract][Full Text] [Related]
23. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. Krcmery V; Oravcova E; Spanik S; Mrazova-Studena M; Trupl J; Kunova A; Stopkova-Grey K; Kukuckova E; Krupova I; Demitrovicova A; Kralovicova K J Antimicrob Chemother; 1998 Mar; 41(3):373-80. PubMed ID: 9578164 [TBL] [Abstract][Full Text] [Related]
24. Fungemia in non-HIV-infected patients: a five-year review. Anunnatsiri S; Chetchotisakd P; Mootsikapun P Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G; J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683 [TBL] [Abstract][Full Text] [Related]
26. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156 [TBL] [Abstract][Full Text] [Related]
27. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981 [TBL] [Abstract][Full Text] [Related]
28. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Schelenz S; Gransden WR Mycoses; 2003; 46(9-10):390-6. PubMed ID: 14622387 [TBL] [Abstract][Full Text] [Related]
29. Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades. Safdar A; Perlin DS; Armstrong D Diagn Microbiol Infect Dis; 2002 Sep; 44(1):11-6. PubMed ID: 12376025 [TBL] [Abstract][Full Text] [Related]
30. [Antifungal therapy for infants, children and adolescents with suspected or documented invasive fungal infection]. Odio CM Drugs Today (Barc); 2010 Apr; 46 Suppl C():33-46. PubMed ID: 20490381 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550 [TBL] [Abstract][Full Text] [Related]